On Jan 18, 2022 Dermaliq Therapeutics closed a Series A round and raised $15,000,000 from 3E Bioventures, Beijing Whale Technology Corporation, featuring lead investors 3E Bioventures.
About the company: Dermaliq Therapeutics is located at United States, North America.
“”
Company website: http://www.dermaliq.com